固醇调节元素结合蛋白和代谢疾病:机制,影响和治疗策略
Xiaofei Zhang1, Kexin Zhang1, Yuqun Wang1
1Department of Endocrinology and Metabolism, Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Metabolic syndrome and related disorders
|December 30, 2025
概括
向固醇调控元素结合蛋白 (SREBPs) 为肥胖和糖尿病等代谢疾病提供治疗潜力. 通过化合物和先进技术调节SREBP活性,可以改善脂质平衡和整体代谢健康.
科学领域:
- 生物化学 生物化学
- 代谢疾病研究研究
- 分子生物学分子生物学
背景情况:
- 由于复杂的因素,代谢性疾病 (肥胖,糖尿病,心血管疾病) 正在增加.
- 固醇调节元素结合蛋白 (SREBPs) 是调节脂质合成和胆固醇平衡的关键转录因子.
- SREBP失调,特别是SREBP-1c过度激活,导致高脂血症并加剧糖尿病和动脉样硬化.
研究的目的:
- 审查在代谢疾病中准SREBP的治疗潜力.
- 探索用于调节SREBP活动的化合物和策略.
- 讨论个性化SREBP向治疗的未来方向.
主要方法:
- 审查关于SREBP功能和治疗干预措施的现有文献.
- 识别调节SREBP活性的化合物 (贝图林,脂肪,桑托胡摩尔,维生素D衍生物,BF175).
- 探索基因编辑技术,如CRISPR-Cas9,用于治疗应用.
主要成果:
- 在实验模型中,几种化合物表现出调节SREBP活性,减少脂质积累和改善代谢结果的能力.
- 准SREBPs显示出治疗高脂血症,糖尿病并发症和动脉样硬化的前景.
- 从了解特定组织的SREBP调节来看,可能会出现个性化的治疗策略.
结论:
- 调节SREBP活动为代谢性疾病提供了可行的治疗策略.
- 小分子调节器和基因编辑技术的进步是开发有效治疗的关键.
- 生活方式干预和药理治疗的结合方法可以优化患者的治疗结果.
相关概念视频
Regulation of Metabolism
11.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.3K
Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Global Regulatory Systems
538
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
538
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Translational Regulation
497
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
497


